Promethera Biosciences Presents Updated Phase 2a Results for World's First Stem Cell Clinical Trial in ACLF at The International Liver Congress/ EASL 2019
MONT-SAINT-GUIBERT, Belgium--(BUSINESS WIRE)--Apr 15, 2019--Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced clinical data…
